1-3 of 3
Jaume Villalta, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reversal of the Antithrombotic Action of Rivaroxaban and Dabigatran: A Clinical Study in Healthy Volunteers.

Ana M Galan, Ph.D., Eduardo Arellano-Rodrigo, MD, PhD, Victoria Veronica Sanz, Patricia Molina, Joan Carles Reverter, MD, PhD, Xavier CarneĢ, MD, PhD, Jaume Villalta, MD, PhD, Dolors Tassies, MD, PhD, Maribel Diaz-Ricart, PhD., Gines Escolar, MD. PhD
Journal: Blood
Blood (2012) 120 (21): 2261.
https://doi.org/10.1182/blood.V120.21.2261.2261
Published: 2012
Journal Articles

Coagulation Factor Concentrates Restore Alterations in Hemostasis Induced by a High Dose of Apixaban: Studies in Vitro with Circulating Human Blood.

Gines Escolar, MD. PhD, Eduardo Arellano-Rodrigo, MD, PhD, Joan Carles Reverter, MD, PhD, Jaume Villalta, MD, PhD, Victoria Veronica Sanz, Patricia Molina, Maribel Diaz-Ricart, PhD., Ana M Galan, PhD.
Journal: Blood
Blood (2012) 120 (21): 2263.
https://doi.org/10.1182/blood.V120.21.2263.2263
Published: 2012
Journal Articles

A Cost-Benefit Analysis of D-Dimer Measurement by a High Sensitivity Asay, as the First Step to Rule out a Venous Thromboembolism Suspected Episode, Independently of Pretest Clinical Probability.

Francesc J Casals, MD, PhD, Davide Bernaudo, MD, Jaume Villalta, MD, Naila Lozano, RN, Gines Escolar, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1280.
https://doi.org/10.1182/blood.V112.11.1280.1280
Published: 2008